Hépato-Gastro & Oncologie Digestive


How to better announce the diagnosis of inflammatory bowel disease? Volume 30, issue 6, June 2023


  • Figure 1

  • Figure 2

  • Figure 3

  • Figure 4

  • Figure 5


1 Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service des maladies de l’appareil digestif, 1 rue Lucie et Raymond Aubrac, 63100 Clermont-Ferrand
2 Université Clermont Auvergne, Inserm U1071, M2iSH, USC-INRA 2018, F-63000 Clermont-Ferrand
3 Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille
* Correspondance : A. Buisson

Inflammatory bowel disease (IBD) is a chronic disease that can significantly impair quality of life. Data on the diagnostic announcement of IBD are almost non-existent. This mini-review summarizes the main results of the ANNONCE-IBD study and proposes tools to help with the announcement of a diagnosis of IBD. In the ANNONCE-MICI study, 708 patients were included. The mean quality of the announcement according to the patients was 6.4 ± 2.8 out of 10. In multivariate analysis, the main factors significantly associated with a better quality of the announcement were: age at diagnosis > 40 years, a diagnosis of Crohn’s disease, a level of education ≤ baccalaureate, an announcement made in a university hospital, and a duration of the announcement > 15 minutes. Only 45 % of patients judged their diagnostic announcement as good (numerical scale ≥ 8). They emphasized a lack of information (53 %) and a consultation time that was too short. The avenues for improvement were: a longer consultation, an additional nursing consultation, the provision of documents on the disease and possible aids. A check-list summarizing the important notions to remember and a proposal for a diagnostic announcement process are proposed in this mini-review to improve the diagnostic announcement of IBD in France.